Washington, DC — The American College of Obstetricians and Gynecologists (The College), along with the American Academy of Pediatrics and the Society for Maternal-Fetal Medicine, is urging Ther-Rx Corporation to reconsider its pricing of Makena™. Makena is the first FDA-approved medication to help prevent preterm birth in certain high-risk pregnant women. The College argues that the extremely high cost of Makena™ will hinder access and affordability to this treatment for both insured and uninsured patients.
To read the full letter, go to http://www.acog.org/from_home/misc/20110311GoedekeLtr.pdf
Hooray, you’re expecting (again)! While you may feel like a pro this time around when it comes to the ins and outs of pregnancy and childbirth, there are still a whole host of things that will feel like foreign territory. Namely, the behaviors and feelings of your beloved firstborn — especially if they are a toddler or preschooler, making the
“Everything is different, but nothing has changed” To our patients, We would like to announce that effective 4/1/2019 BeachesOBGYN will be part of TopLineMD Health Alliance and no longer a member of North Florida OBGYN. We have made this decision to be able to continue to provide the same level of care that our patients have been accustomed. All our
While heart disease may often be considered a primary problem for men, it’s actually the leading cause of death for both men and women. Shocking, right? And though heart disease may be more common in those who are older or post-menopause, it is something that women of all ages should take seriously. In fact, one in three female adults has